Docket #: S20-259
Knock-In of Large DNA for Stable and Long-Term High Genomic Expression
Advances in CRISPR-Cas technology have sparked a multitude of novel gene editing possibilities for therapeutic applications. However, synthetically engineered cells using lentiviral systems or adeno-associated virus (AAV) often do not express transgenes to a high enough concentration and cannot persist for a long period of time. In addition, knock-in (KI) efficiency of gene fragments into a precise genomic locus requires improvement, while maintaining long-term, stable, and high expression of the desired KI fragments.
The Qi lab invented a novel KI system and methodology that increases efficient KI of DNA fragments with stable, long-term genomic expressions. The two-part KI system includes a nuclease system and an engineered pseudovirus system from a lentivirus to enhance KI and gene translocation. This technology enables incorporation of large genes (7-8kB), exceeding the limitations from currently available technology. The technology also allows simultaneous KI of two genes at different genomic loci in a one-pot reaction. After KI, the cargo can be expressed even after months, showing superior expression stability. By increasing the efficiency and efficacy of gene incorporation, followed by stable gene expression, the invention can overcome the current limitations of existing methods and be a valuable tool in advancing cell-based therapies.
Design of KI system: A) the pseudovirus KI template design; B) the nuclease system
Image courtesy the Stanley Qi lab @ Stanford Bioengineering
Stage of Development – Proof of Concept In Vitro
Applications
- Cellular engineering and manufacturing
- T cell therapy (i.e., CAR-T)
- iPSC engineering
- Stem cell therapy
- Cell-based vaccines
Advantages
- More efficient than traditional KI methods
- Can handle large payloads (over 4kbs, high efficient even for payload 7~8kb)
- Long-term, stable, and high gene expression
- Precise insertion of single and multiple gene fragments
Publications
- Chavez, M., Rane, D. A., Chen, X., & Qi, L. S. (2023). Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus. Nature Biomedical Engineering, 1-11.
Related Links
Patents
- Published Application: WO2022104344
- Published Application: 20240018493
Similar Technologies
-
A multiplexed RNA regulation platform for primary immune cell engineering S22-235A multiplexed RNA regulation platform for primary immune cell engineering
-
Detection and prevention of unintended CRISPR/AAV-mediated concatemeric knockins S22-435Detection and prevention of unintended CRISPR/AAV-mediated concatemeric knockins
-
Differential Proliferation of Human HSPCs Using Truncated Erythropoietin Receptors S21-196Differential Proliferation of Human HSPCs Using Truncated Erythropoietin Receptors